Corporate News

News Release
Nielsen BioSciences Announces Appointment of New President and Chief Operating Officer Read More...

Nielsen BioSciences’ SPHERUSOL Provides Physicians with New Test for Valley Fever April 9, 2015
Nielsen BioSciences announced the launch of SPHERUSOL (Coccidioides immitis Spherule-Derived Skin Test Antigen), a skin test that provides valuable data to physicians managing Valley Fever infections. SPHERUSOL has been approved by the U.S. Food and Drug Administration as the only skin test to detect an immune response to the fungus called Coccidioides, or “cocci,” in patients with history of the disease. Read More...

Nielsen BioSciences' SPHERUSOL® Valley Fever Test Incorporated into Medicare Payment for Coccidioidomycosis Skin Test January 26, 2016
Nielsen BioSciences, Inc. announced the Centers for Medicare & Medicaid Services (CMS) have updated the reimbursement rate for the coccidioidomycosis skin test, SPHERUSOL. Read More...

Nielsen expands its corporate headquarters
February 1, 2018 Nielsen more than doubles its space on Flintkote Avenue. Read More...

© 2019 Nielsen BioSciences, Inc.

CANDIN®, ALBICIN®, and SPHERUSOL® are trademarks of Nielsen BioSciences, Inc. All other trademarks are the property of their respective owners.

You Are About to Leave (Nielsen

The following third-party website was provided for your convenience, and Nielsen BioSciences, Inc. does not endorse, verify, or otherwise support the information contained in these websites. You are subject to the legal terms and conditions of use for third-party websites.

The following information is intended for licensed health care providers.

By continuing on to the following pages, you are agreeing that you are licensed in your state as a physician or other health care provider.